Cargando…
A monoclonal natural human IgM protects axons in the absence of remyelination
BACKGROUND: Whereas demyelination underlies early neurological symptoms in multiple sclerosis (MS), axonal damage is considered critical for permanent chronic deficits. Intracerebral infection of susceptible mouse strains with Theiler’s murine encephalomyelitis virus (TMEV) results in chronic induce...
Autores principales: | Wootla, Bharath, Denic, Aleksandar, Warrington, Arthur E., Rodriguez, Moses |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850699/ https://www.ncbi.nlm.nih.gov/pubmed/27126523 http://dx.doi.org/10.1186/s12974-016-0561-3 |
Ejemplares similares
-
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
por: Wootla, Bharath, et al.
Publicado: (2015) -
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis
por: Wootla, Bharath, et al.
Publicado: (2015) -
A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis
por: Xu, Xiaohua, et al.
Publicado: (2015) -
PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation
por: Watzlawik, Jens O., et al.
Publicado: (2013) -
Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease
por: Warrington, A. E., et al.
Publicado: (2008)